The paradigm shift from clipping to coiling and increased demand for minimally invasive surgeries has augmented the demand for the market.

The global Liquid Embolic market is forecast to reach USD 3.27 Billion by 2027, according to a new report by Reports and Data. Embolization is a minimally invasive, non-surgical procedure that involves the selective occlusion of blood vessels, by purposely introducing emboli. The procedure is an alternative to open surgery and is performed by interventional neuroradiologists. Liquid embolic products are used for the embolization of both arterio-venous malformations (AVMs) and aneurysms.

Liquid embolic agents include ethylene vinyl alcohol and cyanoacrylate. These agents are used to prevent blood supply to aneurysm or tumor. It helps in suppressing the growth and any adverse effects suffered by aneurysms and tumors to vital organs. Liquid embolic agents have the advantage over the flexibility and expense, as well as the threat of vascular injury during navigation. The market is expected to grow due to the increasing adoption of liquid embolic agents due to the favorable clinical research results. The growing prevalence of arteriovenous malformation, growth in the incidence of tumors, and aneurysms factors are also driving the growth of the market.

Request a sample Report of Liquid Embolic Market @ https://www.reportsanddata.com/sample-enquiry-form/2690

Market Overview:

The World Health Organization (WHO) declared the severe acute respiratory syndrome novel coronavirus 2 (SARS-CoV-2) outbreak in Wuhan, China, as a worldwide pandemic in December 2019. SARS-CoV-2 infection is classified as a novel coronavirus disease by the WHO. COVID-19 has infected more than 150 million people worldwide, resulting in more than 3 million deaths. COVID-19 has had a big influence on the healthcare business, causing major disruptions throughout the supply chain, from raw materials to manufacture and delivery. The global demand for medical ventilators has prompted manufacturers to increase demand by up to 40% to 50%. Producers have also collaborated in order to meet rising demand. Governments and a variety of organisations, as well as other industry personnel, are all working hard to address the global problem. Leading personnel are active in research and development operations, strategic alliances and collaborations, and creative product releases in order to meet consumer demands for pharmaceuticals, vaccines, diagnostics, and medical equipment such as ventilators. Without a doubt, this is the first time in contemporary history that the diagnostics industry has been given such prominence. Participants in the healthcare business have abruptly shifted from under the carpet to above the carpet's demand. The world has acknowledged the necessity for early warning systems in the healthcare sector, currently for COVID-19, but this pattern will continue in the future for other sorts of diagnostics.

Ask for Order on Liquid Embolic Market Report @ https://www.reportsanddata.com/sample-enquiry-form/2690

Key Players covered in this report are

Medtronic, Cyberonics, InoMed, Boston Scientific, Codman, and Shurtleff. RauMedic, St. Jude Medical, Stryker, Mizuho America, and Integra LifeSciences, among others.

Based on Product Type market is segmented into:

Product Outlook (Revenue, USD Billion; 2016-2027)

• Isobutyl-2-Cyanoacrylate(IBCA)
• Sodium Morrhuate
• Ethanol
• Bletilla Striata

Application Outlook (Revenue, USD Billion; 2016-2027)

• Brain Arteriovenous Malformations
• Tumor and Brain Cancer
• Brain Aneurysm
• Ischemic Stroke

End Users Outlook (Revenue, USD Billion; 2016-2027)

• Hospitals
• Ambulatory Surgical Centers

Based on Region market is segmented into:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East Africa

Further key findings from the report suggest

• Brain Arteriovenous Malformations is the tangle of abnormal blood vessels that connect veins and arteries in the brain. They can develop anywhere in the body and but occurs generally in the spine or brain. The disease are rare and affects less than one percent of the population.
• Hospitals held a major market share as these sophisticated devices are available in bigger hospitals and critical care units. The increasing adoption of minimally invasive surgeries, increase in the purchasing power, and investment into the healthcare sector is boosting the growth of the market.
• Sodium Morrhuate is consumed mainly by injection and is a mixture of salts of the saturated and unsaturated fatty acids of cod liver oil. It is a pale yellow, granular powder with a slight fishy odor and is soluble in water and alcohol.
• North America held the largest market share due to the availability of advanced equipment and quicker adoption of innovative surgeries. The region also invest in research and development heavily.
• The U.S. is the largest market for liquid embolic products. The growth of the market forecasts estimate that the major share of liquid embolic sales are related to the products for the treatment of approved neurovascular indications. However, primary research suggests that off-label usage of liquid embolic agents accounts for a significant percentage of overall utilization.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com